Broyhill
Our archive holds 5 letters from Broyhill, behind 8 investment theses and positions in 9 companies. Every quote below is copied verbatim from the letter it came from.
Get an email when this fund publishes its next letter
3 strategies
Broyhill publishes a letter per strategy. Each one has its own page — what it holds, what it bought, what it wrote.
- Broyhill AM2
4 companies
- Broyhill Equity Highlights2
9 companies
- Broyhill Asset Management1
3 companies
What they bought and sold · 1 move
- ExitedSotera HealthMay 2026
“The sponsors completed a 31.8 million-share secondary in May, fully exiting their Sotera Health positions and terminating the stockholders' agreement that had given them board control.”
Read the letter
Companies held · 9
Every company Broyhill has disclosed a position in across our archive, with the letter that last mentioned it.
- Dollar TreeJul 2026
- HoneywellJul 2026
- LVMHMay 2026
- MascoMay 2026
- MiddlebyJul 2026
- NestléJul 2026
- Philip Morris InternationalMay 2026
- Smurfit WestRockJul 2026
- Sotera HealthMay 2026
Theses · 8
- May 2026
Masco is attractive for its repair-and-remodel exposure, pricing power, growth targets, and shareholder returns.
Read the full thesis - March 2026
Ball Corporation is a pure-play packaging company with capital return potential after its aerospace divestiture.
Read the full thesis - March 2026
IQVIA is a clinical research organization with sticky pharma demand, proprietary data, and valuation support despite AI concerns.
Read the full thesis - March 2026
Sotera Health is a mission-critical sterilization business with a duopoly position and valuation support despite litigation overhangs.
Read the full thesis - March 2026
Masco is a housing-related company whose normalized earnings power has improved through market share gains and expense efficiencies.
Read the full thesis - December 2025
Reckitt Benckiser is a focused hygiene and health company trading at a discount with multiple catalysts and defensiveness.
Read the full thesis - December 2025
Watches of Switzerland is a leading Rolex retailer with a high-margin model and attractive valuation.
Read the full thesis - December 2025
Avantor is a strategic life-sciences supplier with self-help levers amid an industry upturn despite execution issues.
Read the full thesis
Letter archive · 5
Get Broyhill’s next letter the day it lands
We track Broyhill alongside hundreds of other managers, read every letter, and pull out what they bought and sold. Warren AI reads the whole archive for you.
View plans→